Glaukos Corporation

NYSE:GKOS   4:00:00 PM EDT
94.29
+1.60 (+1.73%)
4:02:29 PM EDT: $94.29 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.66B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$79.6 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$89.80
50-Day MA$90.60
200-Day MA$76.68
See more pivots

Glaukos Corporation Stock, NYSE:GKOS

229 Avenida Fabricante, One Glaukos Way, Aliso Viejo, California 92656
United States of America
Phone: +1.949.367.9600
Number of Employees: 907

Description

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.